Hello,
Welcome to Insider
- An Insider analysis found out what 8 top healthcare CEOs made in 2020;
- One bar's outbreak highlights the importance of mitigating the virus with preventive measures;
- What side effects to expect from COVID-19 vaccines, in one chart.
If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...
The CEO of health insurer Cigna made nearly $79 million last year. Here's why 8 top healthcare company execs scored major paydays as the pandemic upended the industry.
- Health-insurer and hospital CEOs scored big paydays in 2020, a year defined by the pandemic.
- Six out of eight CEOs made more last year than in 2019 on stock options and awards.
- The paydays came as big insurers and some health systems grew profits despite COVID-19 challenges.
Check out the chart mapping out compensation here>>
One bar opening caused an outbreak of 46 COVID-19 infections and a school closure affecting 650 kids
- A February bar opening in rural Illinois led to at least 46 COVID-19 cases and a hospitalization.
- It also was linked to a school closure affecting 650 children.
- The case demonstrates the importance of mitigation measures as venues continue to reopen.
One chart shows which vaccine side effects you can expect based on your age, manufacturer, and dose
- All three US-authorized
coronavirus vaccines can bring mild to moderate side effects. - Johnson & Johnson's shot generally has fewer side effects than Pfizer's or Moderna's.
- Elderly people saw fewer side effects than younger adults across all three clinical trials.
More stories we're reading:
- Doctors are criticizing SNL for unfairly stereotyping Black people and vaccine hesitancy (Insider)
- Now is not the time yet to let up on preventive measures against COVID-19 (The Atlantic)
- Fauci says we may be able to go to a movie theater without having to wear masks in 'late fall or early winter' (Insider)
- Bright Health plans to raise $1 billion in an IPO that could happen as soon as late in the second quarter (Bloomberg)
- Lydia